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Background:  Many studies have demonstrated that SPECT Appropriateness Criteria (AC) can improve appropriate use of SPECT over the last 6 
years. However, the predictive powers of indications for clinical outcomes have not been well studied. This study sought to examine the differential 
predictive power of Appropriate Indications (A-I) and Inappropriate Indications (I-I) on clinical outcomes.
Methods:  Consecutive outpatients in Cardiology and Internal Medicine over 12 months were included. Outpatient visit notes, SPECT imaging 
results, and cardiac events (PCI, CABG, MI and death) were analyzed. Statistical analysis was applied to evaluate each specific AC indications and 
their associations with the events. Patient grading was compared to the SPECT AC (2009) as the standard approach using kappa and Kaplan-Meier 
analysis.
Results:  From a total of 926 who had SPECT, 906 were classified into 40 AC. The overall 12 month event rate in patients with SPECT was higher 
in the I-I (N = 318) group than the A-I (N = 512) group (23.6% v. 15.6%, OR 1.7 p < 0.01). In addition, the MI rate in the I-I group was significantly 
higher than the MI rate in the A-I group (8.8% v. 2.7%, OR 3.4, p < 0.001). The most predictive I-Is were: #27 (stable symptoms in known CAD, prior 
stress test done < 2 years ago), and #59 (asymptomatic risk assessment < 2 years after PCI). The most predictive I-Is accounted for 22% of the total 
I-I population. The most predictive A-Is were: #15 (high ATP-III risk asymptomatic patients), #30 (new or worsening symptoms with known CAD), and 
#55 (symptomatic patients post revascularization). None of the uncertain criteria significantly predicted outcomes.
Conclusions:  This is the first study to analyze the differential predictive power of the AC using outcome/Kaplan-Meier survival analysis. In this 
retrospective study, a higher incidence of clinical outcomes was found among I-I criteria. Therefore, some I-I of AC need to be re-evaluated and might 
be reclassified to reflect outcomes. Further research on the AC is necessary to assess the predictive value of individual criteria on outcomes.
